Skip to main content

Table 4 Prediction of Emini surface accessibility for the accessible region

From: Immunoinformatics approach to epitope-based vaccine design against the SARS-CoV-2 in Bangladeshi patients

Start End Peptide Length
113 121 LQSYGFQPT 9
220 228 LQYGSFCTQ 9
284 292 VLSFELLHA 9
302 310 VVVLSFELL 9
562 570 AAYYVGYLQ 9
590 598 AVLYQDVNC 9
48 56 AYSNNSIAI 9
92 100 CVADYSVLY 9
412 420 CVIAWNSNN 9
890 898 CVLGQSKRV 9
131 139 FAMQMAYRF 9
902 910 DVVNQNAQA 9
966 974 AYRFNGIGV 9